Mulpleta

Product manufactured by Shionogi Inc.

Application Nr Approved Date Route Status External Links
NDA210923 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mulpleta Is Indicated For The Treatment Of Thrombocytopenia In Adult Patients With Chronic Liver Disease Who Are Scheduled To Undergo A Procedure. Mulpleta Is A Thrombopoietin Receptor Agonist Indicated For The Treatment Of Thrombocytopenia In Adult Patients With Chronic Liver Disease Who Are Scheduled To Undergo A Procedure. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lusutrombopag LUSUTROMBOPAG ZINC84759273

Comments